Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY ISSUE OF NOVEMBER 05, 2003 FBO #0708
SOLICITATION NOTICE

A -- HIV Vaccine Design and Development Teams

Notice Date
11/3/2003
 
Notice Type
Solicitation Notice
 
Contracting Office
Department of Health and Human Services, National Institutes of Health, National Institutes of Allergy and Infectious Diseases, Contract Management Branch 6700 B Rockledge Room 2230 MSC7612, Bethesda, MD, 20892-7605
 
ZIP Code
20892-7605
 
Solicitation Number
RFP-NIH-NIAID-DAIDS-04-42
 
Response Due
2/19/2004
 
Archive Date
3/5/2004
 
Point of Contact
Janet Mattson, Contracting Officer, Phone 301-496-0993, Fax 301-480-5253, - Janet Mattson, Contracting Officer, Phone 301-496-0993, Fax 301-480-5253,
 
E-Mail Address
jm32u@nih.gov, jm32u@nih.gov
 
Description
The Division of Acquired Immune Deficiency Syndrome (DAIDS) of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), has a requirement for the development of efficacious preventative and therapeutic vaccines against HIV/AIDS for worldwide use in stemming the AIDS epidemic. To augment the vaccine product pipeline, we are seeking opportunities to advance vaccine concepts toward the product stage via a focused, development-based approach. Specifically, the long-range goal of this solicitation is the development of new safe and immunogenic vaccine candidates that merit further evaluation in larger human trials. The HIV Vaccine Design and Development Teams (HVDDT) solicitation seeks to fund consortia of scientists with development experience from industry and/or academia that have 1) identified a promising vaccine concept, and 2) devised a plan for its targeted development into a vaccine product. A vaccine product is defined here to be a material and its manner of administration that could reasonably provide protection against AIDS. Offerors are encouraged, but not required to conduct phase I/II trials in collaboration with NIAID/DAIDS-supported HIV/AIDS vaccine trials networks. Support for phase III studies will not be funded under this solicitation. It is anticipated that up to four (4) cost reimbursement, completion type contracts will be awarded for a period of five (5) years, beginning approximately September 30, 2004. RFP-NIH-NIAID-DAIDS-04-42 will be available electronically on or about November 18, 2003, and may be accessed through the NIAID Contract Management Branch (CMB) Home Page by using the following electronic address and instructions: NIAID/CMB Home Page (via the World Wide Web): Access by using http://www.niaid.nih.gov/contract and select the ?RFPs? link and then select ?RFP-NIH-NIAID-DAIDS-04-42.? Please note that the RFP for this acquisition has been revised to include only the Work Statement, deliverable and reporting requirements, special requirements and mandatory qualification, if any, the Technical Evaluation Criteria, and the proposal preparation instructions. All information required for the submission of an offer will be contained in the electronic RFP package. Following proposal submission and the initial review process, Offerors comprising the competitive range will be requested to provide additional documentation to the Contracting Officer. Responses to this RFP will be due on February 19, 2004. Any responsible Offeror may submit a proposal that will be considered by the Government. This advertisement does not commit the Government to award a contract. Point of Contact: Janet M. Mattson, Contracting Officer Electronic mail address: jm32u@nih.gov Telephone: 301-496-0993 FAX: 301-480-5253 No collect calls will be accepted.
 
Record
SN00463695-W 20031105/031103213115 (fbodaily.com)
 
Source
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  © 1994-2020, Loren Data Corp.